Targeting Chk1 in the replicative stress response

Cell Cycle

Volumn 9, Issue 6, 2010, Pages 1025-

  Dai, Yun ^a   Grant, Steven ^a,b  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

7 HYDROXYSTAUROSPORINE; AZD 7762; CHECKPOINT KINASE 1; CHECKPOINT KINASE 1 INHIBITOR; DNA TOPOISOMERASE INHIBITOR; ENZYME INHIBITOR; GEMCITABINE; NUCLEOSIDE DERIVATIVE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; CANCER COMBINATION CHEMOTHERAPY; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE S PHASE; CELL DEATH; CELL SURVIVAL; CELLULAR STRESS RESPONSE; DNA DAMAGE; DNA REPAIR; HUMAN; NOTE; SIGNAL TRANSDUCTION;

EID: 77953503908     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.9.6.11155     Document Type: Note

References (10)

1. Dai Y, et al. Clin Cancer Res 2010; In press.
2. Kastan MB, et al. Nature 2004; 432:316-23.
3. Sorensen CS, et al. Nat Cell Biol 2005; 7:195-201.
4. Shao RG, et al. Cancer Res 1997; 57:4029-35.
5. Sampath D, et al. Blood 2006; 107:2517-24.
6. Fuse E, et al. Cancer Res 1999; 59:1054-60.
7. George P, et al. Blood 2005; 105:1768-76.
8. Zegerman P, et al. DNA Repair (Amst) 2009; 8:1077-88.
9. Rottenberg S, et al. Proc Natl Acad Sci USA 2008; 105:17079-84.
10. Chen CC, et al. Mol Cancer 2009; 8:24.